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Many regulat:ory p~ptid¢ pr¢c:ursors undergo post.trandationai pro~sstnj at moan. ,tad,or dibasic: residues, Compari:~nn of amino acids around 
the lnon,ohasi~ cleavage site~ sult=ests that these clear qles follow certain ~etiucnce motif~t anti t:a. be described as the rule~ that ttovern monobasi¢ 
gleav;l~e~: (i) a basic amino acid is present at either .L 5, or ? amino acids N.terminal 1o the ¢leavaje site, tii.) hydrophnbi¢ aliphatic amino aetds 
tleucine, isoleucine, valine, or methiontnc) are never pre~ent in the position C-terminal to the monobali¢ amino acid at the cleavage site, till) a 
t:ystcine i~ =lever present in the vicinity ol" the cleavase site. and (iv) an aromatic amino acid is never pre~em at the position N.terminal tt~ the 
monobasic amino acid at the cleavage ~ite. h~ addition to the~e rule~, the monobasi¢ clcavaltes follow certain tendencies: (i) the amino acid at 
tile cleavage ~it¢ tends to In: predominantly arginin¢, tii} the amino ttcid at the po~ition C.tcrrainal to the cleavage site tends to M striae, ahmine 
or 81ycine in more than 60"~ of the cases. (Sill the amino acid at either ~. 5. or ? petition N.tcrminal to the cleavage site tends to t~ aritiaine. 
(iv} aromatic amino a,id, ale rare at the position C.terminal to th¢ mon0basi¢ amino acid at the clcavag© site, and iv) aliphatie amino acids tend 
to ~ in tl~¢ two positlon~ N.terminal to and the two position, C-terminal to the cleavig~ ite. except as noted above. When compared with a 
htr~e number of sequenc=:~ t:0ntaininB single basic amino acids, these rules and tendencies are eu pable of not only correctly predicting the pro¢cssin$ 
sites, hut also are cap;IbM of excluding most of" the single basic: sequences that are known to be uncleared. Many of these rules can al~o be applied 
to corre*:tly predict he dab=tile and multibasic cleavage sites u~scstintl that the rule= and tendencies could govern endoproteolytic processing at 
tit, monobasic, dibasic and multibasic site~. 
NeuropcPtide biosynthesis: Precursor processing; Peptide hormone: Growth factor 
Peptid¢ hormones and neurotransmitters are thought 
to be synthesized as larger precursors that tmdergo 
post-translational modif ications and proteolytic 
cleavages to produce bioactive peptides. The regulatory 
peptides are f lanked by either a dibasic or a monobasic 
processing site. Maturat ion of  these bioactive peptides 
occurs by sequential action of  trypsin-l ike and earbox- 
ypeptidase.B-l ike enzymes Ill. A l though until recently 
only a few prohormones  were known to be processed at 
monobasic  leavage sites, at present a large number o f  
monobasic  leavages are found throughout  he animal 
k ingdom [2-6]. Table I shows the list of  precursors and 
the amino acid sequence around the monobasic  
cleavage site. 
Typically, fewer than 10°70 o f  the single basic se- 
quences within the peptide precursor serve as 
monobasic  leavage sites, In contrast,  the major ity o f  
the dibasic sequences within a peptide precursor usually 
are cleaved. Monobasic  and dibasic cleavage sites also 
differ in the predicted secondary structure surrounding 
these sites, Rho lam et al. [7] proposed that the dibasic 
processing sequences are located in or adjacent to 
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regions with high ,8.turn probabi l i ty [7]. A sinfilar 
analysis on 20 different monobas ic  leavage seqttences 
showed that althougl~ some o f  the sequences were 
predicted to be m or around high/3-turn probabi l i ty,  
many  were not (data not shown). In tt~e ease o f  the 
cleavage sites that contained prol ine either at the N- or  
at the C-terminus of  the processing site, the cleavage 
site was situated in or near an a~-helix. In the case of  the 
sites that did not contain proline, there was no predicted 
conformat iona l  feature that was apparent. This could 
be due to the inability o f  Chou and Fasman analyses to 
accurately predict the secondary structure [8]. 
In order to ascertain if monobas ic  processing follows 
certain consensus equences, Schwartz  [2] compared the 
amino acid sequences around a number  o f  monobas ic  
cleavage sites and postulated that the monobas ic  pro- 
cessing sites can be classified as (i) 'prol ine-directed' 
and (iS) 'non-pro i ine dh'¢cted'. By  a similar analysis o f  
the sequences around the monobas ic  cleavage site, 
BeheSt et al. [3] hypothesized that three principles 
govern the monobasic  cleavages. They are: (i) the 
monobas ic  leavage occurs virtually always at the  car- 
boxyl-terminal end of  an arginine, (iS) a leucine or 
several alanines are virtually always present in the two 
amino  acids immediately N-terminal to and the two 
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=niino acids C-terminal to¢11¢ monobasic cleava[e; (iti) 
three or five or seven amino acids before the arjinine, 
a s~icond arlinine is present; sometimes a histidine (in- 
s(end of an artlinine) is found at this site, The principles 
propos,~d by Benoit et al. were based on analysis of 16 
sinRle basic sequences. Currently there are approx- 
imatdy 1 IOsequenees that are known to be processed at 
proline.containlng and non-proline-containinG 
monobasic sites (including the same peptide in different 
species, and all copies of a peptide when present in 
multiple copies, as in the case: of the caerulein precur- 
sor), The comparison of amino acids around all known 
monobasic leavage sites shows that aU three of the 
previously proposed principles are not entirely valid. 
However, additional rules are apparent from this 
analysis. TheseobServations from the sequences around 
the monobasic leavage sites can be encapsulated as 
four rules that govern monobasic leavages. 
Rule 1. A basic amino acid (Arg, Lys, His) is always 
present either at the - 3, - 5, o r  the - 7 position (3, 
5, or 7 amino acids N-terminal to the cleavage site). 
Rule 2. ,4/iphatic amino acids (Leu, lie, Pal, MeO 
are never present at the + I position (one amino acid 
C.terminal to the cleavage site). 
Rule 3. A Cys is never present in the vicinity o f  the 
cleavage zite, i.e. f rom 7 amino acid N.terminal to 
and 3 amino acids C-terminal to the cleavage site. 
Rule 4. Aromatic  amino acids (Phe, Tyr, Trp) are 
never present at -1  position (one amino acid N. 
terminal to the cleavage site). 
In addition., monobasic cleavages follow certain 
tendencies. They are: 
Tendency t'. The monobasic amino acid at the 
cleavage site is usually an Arg, occasionally a Lys, 
and never a His. 
Tendency 2. Short side chain amino acids, 
predominantly Ser, Ala, or Gly tend to be at the + 1 
position (in approximately 70% of  the cases). 
Tendency 3. The basic amino acid at the - 3, - 5, or 
the - 7 position tends to be Arg fin approximately 
75 % of  the cases). 
Tendency 4. Aromatic amino acids (Trp, Phe, Tyr) 
are rare in the + 1 position. 
Tendency 5. Aiiphatic amino acids (Leu, I/e, Pal, 
M'et) and small side chain amino acids tsar, Ala, 
Gly) often occur in the - 2 position and in the + 2 to 
+ 8 positions. 
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Schwarlx [2] hypothesized chat the proltne.containing 
monobasi¢ cleavatles ~r¢ distinct from the non-prolinc 
containinlJ cleavailes, The consensus site for prolln©. 
directed ¢leav~t$cs i  simply the presence of a proline in 
the - I or the + I position (but never at both positions), 
It is interesting to note Iha¢ In mammals the rules and 
tendencies predicted for non.proline.containinG 
monobasic cleavage sequences also fit the proline. 
containing sequences (Table I). 
The only known exception to rule I is peps]de A of 
Ap/y$ia (9), Peptide A precursor contains a single Lys at 
the -6  position and none at the -3 ,  -5  or the - ' /  
positions. Although the cleavage to release pepdde A Is 
known to occur in the atrial Gland, an identical cleavage 
site in the eJzg laying hormone (ELH) precursor is not 
cleaved in the bag calls [9]. Benoit el al. [3J proposed 
that an Arg or a [=[is at either the -3 ,  -5 ,  or the - . /  
position is a necessary requirement for monobasic 
cleavages. We find that Arg is round predominantly 
(8./%) at the - 3, - 5 or the -'7 position (Tables I and 
II), In the remainingcases either a Lys or a His is found 
in one of these positions. 
In order for a consensus site to be useful in predicting 
which single basic residue becomes a monobasic proc- 
essing site, it is necessary to examine all single basic sites 
present in the regulatory peptides and proteins in the 
secretory granules, When the rules were applied ¢o all 
the single lysines and arginines in approximately 90 
bioactiv¢ peptides that are thought o be unc[eaved, 
90°7o of the cases did not fit the rules. Among the re- 
maining 10~0, very few fit the tendencies in addition to 
the rules. When the rules and tendencies were applied to 
all the single arginines in about 20 proteins that are con- 
tained in the secretory vesicles, in more than 950/0 of the 
cases the single arginines did not fit the rules and 
tendencies. It is possible that those sites that fit both the 
rules and tendencies are processed at that site. Alter- 
natively, secondary and tertiary structure of the pro- 
teins may contribute to the ability of these sites to be 
processed. However, the fact that the rules and tenden- 
cies can exclude > 90°70 of the single basic residues that 
are known to '~e largely uncleared illustrates the value 
of these rul~ in predicting potential cleavage sites. 
The ruF.:s are supported by evidence from naturally 
occurrin~ mutations, both through evolution and 
wil:hin individuals. An example of mutation through 
evolution is that of pancreatic polypeptide [10]. Com- 
pared to the human pancreatic polypeptide precursor 
the primary structure of the guinea pig pancreatic 
polypeptide is missing one of the basic residues from a 
dibasic cleavage site [10] (Fig. 1). The resulting 
monobasic residue fits all the rules and is also processed 
in vivo [lO]. Another example of mutation through 
evolution is that of/3-endorphin [11]. Spiny dogfish B- 
End contains two insertions; a Lys between positions 5 
and 6 and a Trp between positions 6 and 7 of human d- 
End (Fig. 1). As a result of these variations, the single 
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Tobl¢ I 
-8 -7 -6 -5 -4 -3 -2 -I 0 +i +2 +3 +~ +5 +6 +7 +8 Raf 
-Ar~-Arg-Gln-Phe-Lys-Val-Val-Thr-ARG-Se~-Gln-Glu-Asp-Pro-Asn-Ala-Tyr- DynB[31] 
-Asp-Glu-Met-Arg-Leu-Glu-Leu-Gln-ARG-Ser-Ala-Asn-Ser-Asn-Pro-Ala-Met- SS28132] 
-Pro-Leu-Lys-Pro-Ala-Lys-Ser-Ala-ARG-Ser-Val-Arg-Ala-Gln-Arg-His-Thr- ~GFI[33] 
-Ile-Phe-Gln-Val-Leu-Arg-Gly-Val-ARG-Ser-Prc-Lys-Th~-Met-Arg-Asp-Ser- BNP [34] 
-Asp-Lys-Arg-PhemMet-Arg-Phe-Gly-LYS-Ser-Leu-Gly-Thr-Asp-Asp-Val-Asp - FMRF[35] 
-Pro-Arg-Leu-Arp-Gln-Phe-Leu-Gln-L¥S-Ser-Leu-Ala-Ala-Ala-Thr-Gly-Lys- Ant [36] 
-Met-Leu-Thr-Arg-Pro-Arg-Tyr-Gly-L¥S-Ser-Ala-Glu-Glu-Asp-Ala-Leu-Giy- PanP[10] 
-Glu-Glu-Ala-Pro-Arg-Arg-Gln-Leu-ARG-Ala-Val-Leu-Arg-Pro-Asp-Ser-Glu- CC58137] 
-Gly-Ala-Val-Tyr-Gln-Arg-Asp-Leu-ARG-Ala-Pro-Arg-Leu-Arg-Phe-Tyr-Ser- ELM [9] 
-Gly-Val-Gly-Phe-Pro-Arg-Arg-Val-ARG-Ala-Asn-Asp-Arg-Ser-Asn-Ala-Thr- VNII[38] 
-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-ARG-Ala-Arg-Leu-Gly-Arg-Gln-Val-Asp- HGRH[39] 
-GIu-Asp-AIa-His-AIa-Asp-Leu-GIu-ARG-AIa-AIa-Ser-GIy-Gly-Pro-Leu-Leu- SSI [36] 
-GIF-Phe-Met-Lys-Ser-Trp-Asp-Glu-ARG-Gly-Gln-Lys-Pro-Leu-Leu-Thr-Leu- B-En[II] 
-Asp-Asp-Val-Asn-Glu-Arg-Asp-Val-ARG-Gly~Phe-Gly~Ser-Phe~Leu-Gly-Lys- Caer[40] 
-G1u-Asp-Leu-Asp-Glu-Arg-Glu-Val-ARG-Gly Ile-Gly Lys-Phe Leu-1{is-Ser- Mega[41] 
-Asn-Asp-Glu-Val-Glu-Arg-Tyr-Val-ARG-Gly-Trp-Ala-Ser-Lys-Ile-Gly-Gln- Levi[6] 
-Gln-Glu-Gln-Ar~-Ser-Arg-Phe-Asn-ARG-His-Leu-Asp-Arg-Val-Trp-Ala-Glu- RGRH[39] 
-Arg-Asp-Leu-Arg-Trp-Trp-Glu-Leu-ARG-His-Ala-Gly-Tyr-Asp-Gln-Giy-His- EGF [42] 
-Tyr-Tyr-Asp-Val-Ser-Arg-Asn-Ala-ARG-His-Ala-Asp-Gly-Val-Phe-Thr-Ser- PHM [43] 
-Gly-Val-Arg-Ser-Pro-Lys-Thr-Met-ARG-Asp-Ser-Gly-Cys-Phe-Gly-Arg-Arg- BNP [34] 
-Cys-Ala-Thr-Pro-Ala-Lys-Ser-Glu-ARG-Asp-Val-Ser-Thr-Pro-Pro-Thr-Val- IGII[44] 
-Asp-Pro-Ser-His-Arg-Ile-Ser-Asp-ARG-Asp-Tyr-Met-Gly-Trp-Met-Asp-Phe- CO8 [37] 
-Gly-Glu-Asp-Gly-His-His-Leu-Asp-ARG-Asn-Ser-Tyr-Pro-Giy-Cys-Pro-Ser- EGF [42j 
-Ala-Leu-Gly-Ser-Gln-Arg-Glu-Gly-ARG-Asn-Pro-Gln-Leu-Asn-Gln-Gln GRP [45] 
-Arg-Gly-Ala-Arg.Ala-Arg-Leu-Gly-ARG-Gln-Val-Asp-Ser-Met-Trp-Ala-Glu- HGRH[39] 
-Ala-Arg-Leu-Gly-Ala-Leu-Leu-Ala-ARG-Tyr-Ile-Gln-Gln-Val-Arg-Lys-Ala- CC39137] 
-Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-ARG-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln- Dyna[31] 
-Gly-Gly-Phe-Met-Arg-Arg-Val-Gly-ARG-Pro-Glu-Trp-Trp-Met-Asp-Tyr-Gln- Enk [46] 
-Leu-Arg-Ala-Leu-Leu-Ala-Gly-Pro-ARG-Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe- ANF [47] 
-Gly-Ser-Pro-His-Ala-Ala-Val-Pro-ARG-Glu-Leu-Ser-Prc-Leu-Asp=Leu PIP [i0] 
This is a partial list of sequences including only .an example from a 
representative species and a single copy of a peptide when present in multiple 
copies, as in the case of FMRF-amide. The monobasic amino acid at the cleavage 
site is designated as 0, the positions C-terminus to the cleavage site are 
designated as +1, +2, etc and the positions N-terminus to the cleavage site are 
designated as - i , -2 ,  etc. Abbreviations: Ref; References, Dyn B; Dynorphin B, 
SS28; Somatostatin 28, IGFI; Insulin-like Growth Factor i, BNP; Brain 
Natriuretic Peptide, FMRF; FMRF-amide, Ant; Antrin, PanP; Pancreatic 
Polypeptide, CC58; Cholecystokinin-58, E~H; Egg-Laying Hormone, VNII; 
Vasopressin/Neurophysin If, HGRH; Human Growth Hormone Releasing Hormone, SSl; 
anglerfish somatostatin i, ~-En; ~-endorphin, Caer; caerulein, Mega; megainin, 
Levi; levitide, RGR/4; rat growth hormone releasing hormone, EGF; Epidermal 
Growth Factor, PHM; Peptide Histidyl Methionine, IGII; insulin-like growth 
factor If, CC8; cholecystokinin-8, GRP; Gastrin Releasing Peptide, CCK-39; 
cholecystokinin-39, Dyn8; dynorphin A-8, Enk; enkephalin, ANF; Atrial 
Natriuretic Factor, PIP; Pancreatic Icosa Peptide. 
Arg in the dogfish/f-End fits the rules and tendencies 
but the human ,~-End does not. The fact that only the 
dogfish h'-End, and not the human B-End is processed 
further supports the view that the rules correctly predict 
a processing site. Variants of proinsulin [12] and pro- 
albumin [13] have been found in which the peptide is 
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Table II 
Frequency of the r~sldu~ i. ~.d Around ~he I I0 scqu~n~e.s cont~inin~ monob~sl¢ ~Ic~v~ll~ ~i~ for # l'cw ~¢I¢c~ ~iml.o ~¢Id~ (.i~r~.~¢nt¢'J' ~ ~ p~r. 
cenmue). Th~ desillnatlon of silcs Is d~*:rib~d in I~ll~.d to Tabl~ I
, , , ,  , ,  
-7  -6  -5  -4  -3  -2  -1  0 +1 +2 +3 +4 
Arg  12 15 I0 4 76  4 0 81 0 2 4 8 
Lys 16 3 1 4 6 0 0 19 0 1 8 6 
Set 6 8 3 4 0 6 0 0 36  9 7 22 
Ala  7 8 0 7 2 0 I0  0 12 II 12 7 
Gly 4 5 3 0 0 2 40 0 21 0 14 9 
Leu 4 I0 1 ii 2 14 4 0 0 14 2 5 
Val 1 8 4 2 3 5 23 0 0 8 1 0 
not processed and circulates in sera as the unprocessed 
precursor, Upon analysis o f  these variants, the amino 
acid sequence showed that one of the amino acids from 
a dibasic cleavage site was replaced by a His in the case 
of proinsulin and Gin in the case of  proalbumin (Fig. 
1). In these examples the resulting single basic amino 
acids do not fit the rules, and the lack of processing in 
vivo, lends further support o the validity of the propos- 
ed rules. 
To see if these rules and tendencies could be extended 
to the dibasic cleavages, 70 dibasic sites that are known 
to be processed were examined. Approximately 70~/~ of 
the examples fit all 4 rules and 97O7o fit at least 3 rules. 
In contrast, when the dibasic sites that are not cleaved 
were examined, only 16% fit all of  the rules, and 45°7~ 
fit at least three rules. Although these rules and tenden- 
cies are different from the observations described by 
Harris [14], there are some similarities. Harris noted 
that the primary recognition site involved in dibasic 
processing contains a monobasic or a strongly polar 
rcsidue in the vicinity of  the cleavage site. 
The proposed rules and tendencies also could be ex- 
tended to multibasic processing that occurs in the 
secretory pathway. Examples include: the formation of  
some peptide hormones, blood coagulation factors and 
receptors for insulin and insulin-like growth Factor-I 
(IGF-I). A number of  blood factors, such as factor VII, 
factor IX, factor X, prothrombin, and protein S, are 
synthesized as precursors that undergo post- 
translational processing at multibasic sites prior to 
secretion into the blood [15-20]. It has also been shown 
that the insulin receptor and IGF-I receptor equire 
processing at a tetrabasic site to release the a, and ,6' 
subunits [21,221. Carboxypeptidase E (CPE, an enzyme 
involved in peptide biosynthesis) is synthesized as a 
precursor that contains a pentabasic sequence and pro- 
cessing at the site would release mature CPE [23]. It is 
clear from comparing the sequences that the processing 
at multibasic sites also follows all the rules and some of 
the tendencies. The involvement of  a basic amino acid 
at the -3  position is highlighted by  the unprocessed 
naturally occurring variants of factor IX (Ox3 factor IX 
and factor IX cambridse) and an insulin receptor mutant 
[15,24,25]. In Ox3 factor IX a mutation of the Arg at 
the - 3 to Gin resulted in the absence of processing at 
the tetrabasic site [15]. In factor IX cambr|dse a mutation 
Human PP 
Guinea p ig  PP 
Human E-End 
Dogf ish ~-End 
Pro insu l in  
Pro insu l in  var iant  
Proa lbumin  
Proa lbumin var iant  
-7 -6 -5 -4 -'3 -2 -I 0 +I +2 +3 +4 
-Leu-Thr -Arg -Pro -Arg -Tyr -G ly -s -~. -H is -Lys -G lu -  
- Leu-Th~-Arg -Pro - ,Arg -Tyr -G ly -~-Ser -A la -G lu -G lu -  
-Phe-Met-  -Thr-  -Ser -G lu -Lys -Ser -G ln -Thr -Pro -  
-phe-Met-Lys-Ser-Trp-Asp-Glu-A_r_q-Gly-Gln-Lys-Pro- 
-A la -Leu-G lu -G ly -Ser -Leu-G ln -~-G ly~l le -Va l  - 
-A la-Leu-Glu-Gly-Ser-Leu-Gln-Lys-~[ is -Gly- l le -Val -  
Arg- ,Gly-Val -Phe-Ar~-Ar~-Glu-Als -His -  
Arg -G ly -Va l -Phe-Arg -G ln -G lu -A la -H is -  
Fig. 1. Comparison of amino acid sequences around the cleavage sites. The designation of sites is in the legend to Table 1. The basic amino acids 
involved in cleavages are underlined. PP = pancreatic polypeptide; b.End =b'-endorphin. 
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of  the ¢l¢avage ~ite from Ar~l-Pro-Lys-Aqt to Arg-Pro- 
Lys-Ser resulted in the absence of processing [24]. in th, 
in'..ulin receptor, a mutation of Ar~.Lys-Ar~t=Arg to 
ArEl,.Lys.Arg.$¢t resulted in the lack of proeessinl$ [2,~], 
The absence of a basle amino acid at the - 3 position 
could explain the absence of processing in these two ex- 
amples. 
It could be hypothesized that one or ~everal related 
cndoproteases is/are involved in processing at 
monobasic, dibasic, and multibasic cleavage sites. A 
number of putative processing enzymes selective for 
dibasic [261 and monobasic [271 cleavage sites have been 
reported. In most cases, these enzymes have been 
reported to be specific either for dibasic or monobasi¢ 
sites and it is therefore unlikely that a single enzyme 
perforn~s both cleavages in viva. Two monobasic pep- 
tide processing enzymes, a dynorphin converting en- 
zyme from rat brain and a eaerulein processing frog 
skin endoprotease, have been shown to have a require- 
ment for a basic amino acid either at the - 3, - 5 or the 
- ? sites [28=30]. Also1 the frog skin endoproteas¢ does 
not tolerate an aliphatic amino acid at the + 1 site (rule 
no. 2) and partially tolerates an aromatic amino acid at 
the -1  site (rule ~1o. 4) [30]. It is exciting that the 
monobasic processing enzymes display substrate 
specificity consistent with the proposed rules that were 
generated entirely by comparing sequences. As more 
monobasic leavage sites become known, it is likely that 
a further refinement of the rules and tendencies describ. 
ed here will be possible. A consensus ite for predicting 
cleavage sites is important, both for the studies on pep. 
tides and processing enzymes. It is hoped that the pres- 
ent description of the rules for monobasic cleavage sites 
will be useful for these purposes. 
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